Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-150.72
Price to sales ratio
13.58

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
106
DHR
Danaher Corporation Common Stock
200.11 USD+0.59%+3.69%+10.56%+0.31%141.63 B USD
344
IDXX
IDEXX Laboratories, Inc. - Common Stock
562.22 USD-0.24%+0.11%+0.68%+5.94%44.35 B USD
389
A
Agilent Technologies, Inc. Common Stock
133.96 USD-0.28%+2.42%+2.72%+10.02%37.83 B USD
396
WAT
Waters Corporation Common Stock
373.64 USD-0.73%-0.62%+2.47%+17.05%36.69 B USD

Frequently asked questions about Natera, Inc. - Common Stock

What is the Natera, Inc. - Common Stock stock price today?

The current price of Natera, Inc. - Common Stock (NTRA) is 269.85. Over the past 24 hours, the stock has changed by -0.04%. Follow the NTRA chart for real-time price dynamics.

What is the stock ticker of Natera, Inc. - Common Stock?

Natera, Inc. - Common Stock trades under the ticker NTRA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Natera, Inc. - Common Stock stock going up?

NTRA has changed by -4.77% over the last week, +23.56% over the last month, and +68.48% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Natera, Inc. - Common Stock net income for the last quarter?

Natera, Inc. - Common Stock reported net income of -85.09 M for the last quarter. The previous quarter showed 47.26 M, which means net income changed by -280.06%.

How many employees does Natera, Inc. - Common Stock have?

As of the latest available data, Natera, Inc. - Common Stock has 6 140 employees. Workforce size can provide additional context about the company's scale and operations.

What is Natera, Inc. - Common Stock EBITDA?

Natera, Inc. - Common Stock EBITDA is -78.78 M, and its EBITDA margin is -11.3%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Natera, Inc. - Common Stock stock?

You can buy Natera, Inc. - Common Stock (NTRA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Natera, Inc. - Common Stock stock?

Investing in Natera, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NTRA chart and related analysis on metatrader.com as part of your research.

Natera, Inc. - Common Stock

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas.

News